ADAR and COVID-19: Further, as elevation of ADAR1 RNA-editing has been previously observed to be transient in COVID-19 patients [23], the connection between ADAR1 RNA-editing and T cells will be relevant towards investigating whether ADAR1 RNA-editing plays a role in long COVID-19, debilitating illness as a result of COVID-19 infection [56].